| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268247 | Journal of Clinical Virology | 2005 | 7 Pages |
Abstract
In patients having a TI in the context of VF, archiving of resistant HIV-1 variants in proviral DNA can be involved into the mechanisms of further VF after treatment resumption.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Sébastien Boucher, Patricia Recordon-Pinson, Didier Neau, Jean-Marie Ragnaud, Karine Titier, Muriel Faure, Hervé Fleury, Bernard Masquelier,